Ostial Corporation develops the FLASH™ Aorto‑Ostial Angioplasty System, a dual‑balloon angioplasty catheter designed to deliver complete 360° stent apposition at the ostium. The FLASH System is commercially available in the U.S. and is sold in 350 hospitals with 19,000 commercial units sold to date. Ostial intends to use recent growth funding to double its sales force, execute national programs, expand clinical research and its scientific advisory, and commence development of the next‑generation FLASH System. Management has said the company will also seek partnerships to expand its broader cardiovascular platform beyond FLASH. Ostial is an Incept LLC portfolio company headquartered in Campbell, California. The company positions the FLASH System to improve reaccess for future interventions and optimize patient outcomes in high‑risk coronary and peripheral cases.

Total raised

$8M

Funding rounds

1

Latest round

Series C

Latest activity

Feb 2023